Ro60-0175 free base

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 556329

CAS#: 169675-08-5 (free base)

Description: Ro60-0175 is a potent and selective SR-2 agonist. It shows selectivity for the 5-HT2C subtype (pKi values are 9, 7.5, 5.4, 5.2 and 5.6 for human 5-HT2C, 2A, 1A, 6 and 7 receptors respectively). Ro60-0175 acts as a potent and selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes, with good selectivity over the closely related 5-HT2A subtype, and little or no affinity at other receptors.

Chemical Structure

Ro60-0175 free base
CAS# 169675-08-5 (free base)

Theoretical Analysis

MedKoo Cat#: 556329
Name: Ro60-0175 free base
CAS#: 169675-08-5 (free base)
Chemical Formula: C11H12ClFN2
Exact Mass: 226.07
Molecular Weight: 226.679
Elemental Analysis: C, 58.29; H, 5.34; Cl, 15.64; F, 8.38; N, 12.36

Price and Availability

Size Price Availability Quantity
50mg USD 550 2 Weeks
100mg USD 950 2 Weeks
200mg USD 1650 2 Weeks
500mg USD 2650 2 Weeks
1g USD 3850 2 Weeks
2g USD 6450 2 Weeks
Bulk inquiry

Related CAS #: 169675-09-6 (fumarate)   169675-08-5 (free base)    

Synonym: Ro60-0175; Ro-60-0175; Ro 60-0175; Ro600175; Ro-600175; Ro 600175;

IUPAC/Chemical Name: (S)-1-(6-chloro-5-fluoro-1H-indol-1-yl)propan-2-amine


InChi Code: InChI=1S/C11H12ClFN2/c1-7(14)6-15-3-2-8-4-10(13)9(12)5-11(8)15/h2-5,7H,6,14H2,1H3/t7-/m0/s1

SMILES Code: C[C@H](N)CN1C=CC2=C1C=C(Cl)C(F)=C2

Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 226.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Micioni Di Bonaventura E, Botticelli L, Del Bello F, Giorgioni G, Piergentili A, Quaglia W, Cifani C, Micioni Di Bonaventura MV. Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior. Pharmacol Res. 2021 Oct;172:105847. doi: 10.1016/j.phrs.2021.105847. Epub 2021 Aug 24. PMID: 34438062.

2: Pratt WE, Vaca-Tricerri R, Blanchard AC, Hopkins TR, Ilesanmi AO, Pierce- Messick Z, Rosner IA, Ying R. Selective serotonin receptor stimulation of the ventral tegmentum differentially affects appetitive motivation for sugar on a progressive ratio schedule of reinforcement. Behav Brain Res. 2021 Apr 9;403:113139. doi: 10.1016/j.bbr.2021.113139. Epub 2021 Jan 23. PMID: 33497748; PMCID: PMC7902372.

3: Cedillo LN, Ruíz-García RI, Jiménez JC, Miranda F. Effect of coadministration of the GABAB agonist baclofen and the 5-HT2C agonist Ro60-0175 on the expression of amphetamine-induced locomotor sensitization. Exp Brain Res. 2019 Jul;237(7):1691-1697. doi: 10.1007/s00221-019-05540-z. Epub 2019 Apr 15. PMID: 30989246.

4: Howell E, Baumgartner HM, Zallar LJ, Selva JA, Engel L, Currie PJ. Glucagon- Like Peptide-1 (GLP-1) and 5-Hydroxytryptamine 2c (5-HT2c) Receptor Agonists in the Ventral Tegmental Area (VTA) Inhibit Ghrelin-Stimulated Appetitive Reward. Int J Mol Sci. 2019 Feb 19;20(4):889. doi: 10.3390/ijms20040889. PMID: 30791361; PMCID: PMC6412472.

5: Colangeli R, Di Maio R, Pierucci M, Deidda G, Casarrubea M, Di Giovanni G. Synergistic action of CB1 and 5-HT2B receptors in preventing pilocarpine-induced status epilepticus in rats. Neurobiol Dis. 2019 May;125:135-145. doi: 10.1016/j.nbd.2019.01.026. Epub 2019 Feb 1. PMID: 30716469.

6: Sasamori H, Ohmura Y, Kubo T, Yoshida T, Yoshioka M. Assessment of impulsivity in adolescent mice: A new training procedure for a 3-choice serial reaction time task. Behav Brain Res. 2018 May 2;343:61-70. doi: 10.1016/j.bbr.2018.01.014. Epub 2018 Jan 31. PMID: 29355672.

7: Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate. Psychopharmacology (Berl). 2017 Mar;234(5):889-902. doi: 10.1007/s00213-017-4529-5. Epub 2017 Jan 18. PMID: 28097374.

8: Ohyama M, Kondo M, Yamauchi M, Imanishi T, Koyama T. Asenapine reduces anxiety-related behaviours in rat conditioned fear stress model. Acta Neuropsychiatr. 2016 Dec;28(6):327-336. doi: 10.1017/neu.2016.17. Epub 2016 Apr 21. PMID: 27099073.

9: Yang J, Jin HJ, Mocaër E, Seguin L, Zhao H, Rusak B. Agomelatine affects rat suprachiasmatic nucleus neurons via melatonin and serotonin receptors. Life Sci. 2016 Jun 15;155:147-54. doi: 10.1016/j.lfs.2016.04.035. Epub 2016 May 24. PMID: 27269050.

10: Han LN, Zhang L, Li LB, Sun YN, Wang Y, Chen L, Guo Y, Zhang YM, Zhang QJ, Liu J. Activation of serotonin(2C) receptors in the lateral habenular nucleus increases the expression of depression-related behaviors in the hemiparkinsonian rat. Neuropharmacology. 2015 Jun;93:68-79. doi: 10.1016/j.neuropharm.2015.01.024. Epub 2015 Feb 7. PMID: 25661701.

11: Mizoguchi K, Kushida H, Kanno H, Igarashi Y, Nishimura H, Ikarashi Y, Kase Y. Specific binding and characteristics of geissoschizine methyl ether, an indole alkaloid of Uncaria Hook, in the rat brain. J Ethnopharmacol. 2014 Dec 2;158 Pt A:264-70. doi: 10.1016/j.jep.2014.10.015. Epub 2014 Oct 31. PMID: 25456433.

12: Orban G, Bombardi C, Marino Gammazza A, Colangeli R, Pierucci M, Pomara C, Pessia M, Bucchieri F, Benigno A, Smolders I, De Deurwaerdère P, Di Giovanni G. Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats. CNS Neurosci Ther. 2014 Jul;20(7):651-61. doi: 10.1111/cns.12285. Erratum in: CNS Neurosci Ther. 2014 Oct;20(10):950. Arcangelo, Benigno [corrected to Benigno, Arcangelo]. PMID: 24935789; PMCID: PMC6493041.

13: Kasper J, Tikamdas R, Kim MS, Macfadyen K, Aramini R, Ladd J, Bisceglia S, Booth R, Peris J. The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats. Eur J Pharmacol. 2013 Oct 15;718(1-3):98-104. doi: 10.1016/j.ejphar.2013.09.008. Epub 2013 Sep 13. PMID: 24041931; PMCID: PMC3833445.

14: Burton CL, Rizos Z, Diwan M, Nobrega JN, Fletcher PJ. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats. Behav Brain Res. 2013 Mar 1;240:171-81. doi: 10.1016/j.bbr.2012.11.030. Epub 2012 Nov 28. PMID: 23201361.

15: Fletcher PJ, Soko AD, Higgins GA. Impulsive action in the 5-choice serial reaction time test in 5-HT₂c receptor null mutant mice. Psychopharmacology (Berl). 2013 Apr;226(3):561-70. doi: 10.1007/s00213-012-2929-0. Epub 2012 Nov 29. PMID: 23192316.

16: Navailles S, Lagière M, Roumegous A, Polito M, Boujema MB, Cador M, Dunlop J, Chesselet MF, Millan MJ, De Deurwaerdère P. Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. Int J Neuropsychopharmacol. 2013 Apr;16(3):593-606. doi: 10.1017/S1461145712000417. Epub 2012 May 3. PMID: 22717119.

17: Fletcher PJ, Rizos Z, Noble K, Soko AD, Silenieks LB, Lê AD, Higgins GA. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology. 2012 Jun;62(7):2288-98. doi: 10.1016/j.neuropharm.2012.01.023. Epub 2012 Feb 8. PMID: 22342986.

18: Agnoli L, Carli M. Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task. Psychopharmacology (Berl). 2012 Jan;219(2):633-45. doi: 10.1007/s00213-011-2581-0. Epub 2011 Nov 24. PMID: 22113450.

19: Fletcher PJ, Rizos Z, Noble K, Higgins GA. Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade. Neuropharmacology. 2011 Sep;61(3):468-77. doi: 10.1016/j.neuropharm.2011.02.025. Epub 2011 Mar 21. PMID: 21402085.

20: Fletcher PJ, Sinyard J, Higgins GA. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav. 2010 Nov;97(1):170-8. doi: 10.1016/j.pbb.2010.07.002. Epub 2010 Jul 16. PMID: 20624416.